Send Thanks! A link has been sent. The caveat, in the eyes of many, is that the worlds largest ETF issuer continues to cede market share to Vanguard. Pennsylvania-based Vanguard is the third-largest U.S. ETF issuer.
ETF Halftime Report: 2013's Losers Lead, Vanguard Hauls It In - Bloomberg
4.8%, France 4.3%, Norway 4.3%, Canada 3.0%, Finland 2.9% and Spain 2.7%. The funds market-cap breakdown includes mega-caps 19.7%, large-caps 44.2%, mid-caps 35.2% and small-caps 1.0%. The portfolio shows a price-to-earnings ratio of 15.2. The ETF is up 3.5% over the past month, up 9.6% over the last three months home page and up 8.1% year-to-date. IDHB is 8.9% above its 200-day exponential moving average.
ETF Spotlight: High-Beta, Developed Market Stocks | ETF Trends
What to expect in the second half? We'll see the first-ever credit default swap ETFs . And non-transparent actively managed ETFs look likely to win approval by the Securities and Exchange Commission. That would open the floodgates for giant mutual fund firms to launch more actively managed ETFs. That's because the ETFs wouldn't have to show the world their holdings -- be transparent -- every day, which was a major concern of the firms.
ETF Preview: ETFs, Futures Flat to Weaker Ahead of Pending Home Sales, Chicago PMI Data - NASDAQ.com
stock futures were flat to weaker, but market sentiment is optimistic as investors look forward to the end of Q2, which is expected to close with gains at the highest level since 2009. Economic data is also on tap - the Chicago Purchasing Managers' Index for June will be reported 9:45 am ET, while the National Association of Realtors' gauge of pending home-sales for May will be released at 10 am ET. In corporate news, Alimera Sciences (ALIM) was up more than 4% after it said it received a positive outcome of the repeat-use procedure for ILUVIEN for the treatment of chronic diabetic macular edema in an additional 10 European Union countries. Alimera submitted the application through the Mutual Recognition Procedure with the Medicines and Healthcare products Regulatory Agency of the U.K. serving as the Reference Member State. Under that procedure, a Marketing Authorization Holder can use the MRP for the same authorization more than once after completion of a first decentralized procedure and obtain marketing authorization in other Member States.
Does Dividend-Paying IBM or Altria Deserve a Berth in Your Portfolio?
IBM is the king of patents , actually, with more than 6,800 awarded last year and more than $1 billion generated annually from royalties. For patient believers, IBM stock offers a dividend yield of about 2.4%, and with a forward P/E ratio of nine, its stock is intriguing . A closer look at Altria Group (and Philip Morris International) There are a lot of reasons to pass up investing in the tobacco giant Altria: rising taxes on tobacco, increased regulations, competition from discount cigarettes, and a shrinking smoker base. These have led plenty of people to favor the company's nondomestic counterpart, Philip Morris International (NYSE: PM ) , as it's viewed as facing fewer challenges and offering more growth potential, as it operates in emerging markets, where growing middle classes will smoke more cigarettes.